Texas Instruments director receives stock and options
Texas Instruments director Martin S. Craighead reported equity awards from the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Texas Instruments director Martin S. Craighead reported equity awards from the company. On January 29, 2026, he received 525 shares of common stock at $0 under the Texas Instruments 2018 Director Compensation Plan, bringing his directly held common stock to 24,359 shares.
On the same date, he was also granted a non-qualified stock option for 1,860 shares with an exercise price of $218.97 per share. This option becomes exercisable in four equal installments beginning January 29, 2027 and runs until January 29, 2036.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | NQ Stock Option (Right to Buy) | 1,860 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 525 | $0.00 | $0.00 |
Footnotes (2)
- F1. Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan.
- F2. The stock option becomes exercisable in four equal installments beginning on January 29, 2027.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Texas Instruments (TXN) disclose in this Form 4?
What are the terms of the new stock options granted by Texas Instruments (TXN)?
Is the Texas Instruments (TXN) director’s new equity award a purchase or a grant?
When can the Texas Instruments (TXN) director exercise his new stock options?
AI-generated analysis. How Rhea-AI works. Not financial advice.